| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/21/2011 | WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011029102A3 Cd117+cells and uses thereof |
| 07/21/2011 | US20110178488 Sexual Hygienic Composition |
| 07/21/2011 | US20110178168 Coumarin compounds for the treatment of cardiovascular diseases and a process for preparing the same |
| 07/21/2011 | US20110178135 Salts and crystalline forms of a factor xa inhibitor |
| 07/21/2011 | US20110178130 MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 07/21/2011 | US20110178104 Anti-Heparin Compounds |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178063 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 07/21/2011 | US20110178039 Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them |
| 07/21/2011 | US20110178019 New protecting compositions for recombinantly produced factor viii |
| 07/21/2011 | US20110178018 Novel selenium-containing compounds |
| 07/21/2011 | US20110178016 Pulse parathyroid hormone for treatment of the hematopoietic syndrome, stromal cell loss, and vascular injury resulting from acute exposure to lethal radiation |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177172 Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and gi inflammation inhibiting agents) compositions for anaemia or h. pylori infections |
| 07/21/2011 | US20110177167 Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177107 Predicting and reducing alloimmunogenicity of protein therapeutics |
| 07/21/2011 | US20110177033 Ras responsive element binding protein 1 (rreb1) as a therapeutic target for thalassemias and sickle cell anemia |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/20/2011 | EP2345724A1 G-CSF analog compositions and methods |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345650A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| 07/20/2011 | EP2345433A1 Tissue plug |
| 07/20/2011 | EP1361884B1 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 07/20/2011 | CN1931214B Medicine composition of rhodiola root and puerarin |
| 07/20/2011 | CN1814250B Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof |
| 07/20/2011 | CN102131929A Endogenous short hairpin rna and use of same |
| 07/20/2011 | CN102131802A New heterocyclic carboxamides for use as thrombin inhibitors |
| 07/20/2011 | CN102127145A Substituted tetrahydroisoquinoline compound as well as preparation method and application thereof |
| 07/20/2011 | CN102127097A N-(3S-1, 2, 3, 4- tetrahydroisoquinoline-3-formoxyl) cupric amino-acid complex, preparation method and application of complex |
| 07/20/2011 | CN102127079A Pyrrolo-pyrazin-carboline diketone compounds and preparation method and applications thereof |
| 07/20/2011 | CN102127054A 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite |
| 07/20/2011 | CN102125690A Application of polyphenol components in preparation of medicaments for treating aspirin resistance |
| 07/20/2011 | CN102125665A Active plaster for treating blood stasis of human bodies |
| 07/20/2011 | CN102125631A Astringing hemostasis medicine |
| 07/20/2011 | CN102125571A Dammarane aglycon compound and application thereof |
| 07/20/2011 | CN102125570A Use of chikusetsusaponin v and/or total saponins of panax japonicas in preparation of antithrombotic agents |
| 07/20/2011 | CN102125568A Medicinal composition containing clopidogrel and aspirin and application thereof to preparation of medicaments for treating acute non-disabling cerebrovascular diseases |
| 07/20/2011 | CN102125543A Heparin-free anticoagulant infection inhibitor for hemodialysis and preparation method thereof |
| 07/20/2011 | CN101843876B Chinese medicinal composition for preventing renal cell apoptosis and anemia caused by cis-platinum (DDP) and preparation method thereof |
| 07/20/2011 | CN101721449B Method for preparing lindley eupatorium herb general flavone by using attapulgite adsorption method |
| 07/20/2011 | CN101623448B Medicine for treating cerebral thrombosis |
| 07/20/2011 | CN101585842B Research and control method of impurity B control method in clopidogrel |
| 07/20/2011 | CN101544614B Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 07/20/2011 | CN101508684B Synthesis of cinepazide maleate |
| 07/20/2011 | CN101449659B Environment regulating agent and production method thereof |
| 07/20/2011 | CN101371869B Inhibitor originated from alpha-glucosidase of natto and preparation method thereof |
| 07/20/2011 | CN101361980B Heparin phospholipid composite suitable for non-injection administration and preparation method thereof |
| 07/20/2011 | CN101337891B Nitric oxide donor type 3-butylphthalide derivates, method for preparing same and pharmaceutical use |
| 07/20/2011 | CN101244206B Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
| 07/20/2011 | CN101172129B Traditional Chinese medicine composition for treating hypodermal ecchymosis and method of preparing the same |
| 07/20/2011 | CN101152246B Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 07/20/2011 | CN101084911B Notoginsenoside sodium freezing-dried emulsion and preparation method thereof |
| 07/20/2011 | CN101076519B Amide compound and thrombopoietin receptor activator |
| 07/20/2011 | CA2784918A1 Antimir-451 for the treatment of polycythemias |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981865 Antigenic fragments of human factor VIII polypeptides |
| 07/19/2011 | US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 07/19/2011 | US7981448 Method of treating necrotizing enterocolitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient. |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011084653A1 Crystalline forms of the mesylate salt of a factor xa inhibitor |
| 07/14/2011 | WO2011084652A2 Salts and crystalline forms of a factor xa inhibitor |
| 07/14/2011 | WO2011084519A1 Methods of synthesizing factor xa inhibitors |
| 07/14/2011 | WO2011083810A1 Imino derivatives, process for preparation thereof, and insecticides containing same |
| 07/14/2011 | WO2010049709A8 Therapeutic compositions comprising phenolic acids for treating conditions related to inappropriate platelet aggregation |
| 07/14/2011 | US20110173707 System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity |
| 07/14/2011 | US20110172580 Wound care dressing |
| 07/14/2011 | US20110172278 Compounds and methods for modulating g protein-coupled receptors |
| 07/14/2011 | US20110172273 Methods of treating myelodysplastic syndromes using lenalidomide |
| 07/14/2011 | US20110172263 Indole derivatives as crth2 receptor antagonists |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172232 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110172194 Composition of dialysis liquid comprising crystallisation inhibitor substances |
| 07/14/2011 | US20110172189 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use |
| 07/14/2011 | US20110172182 Carboxyethylated Cyclodextrin Polysulfates Useful As Medicaments |
| 07/14/2011 | US20110172171 Taurine or taurine-like substances for the prevention of brain oedema |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172156 Methods and compositions for treating bleeding disorders |
| 07/14/2011 | US20110172141 Process for preparing microparticles |
| 07/14/2011 | US20110172140 Poly-Pegylated Protease Inhibitors |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171317 Method for inhibiting accumulation of visceral fat |
| 07/14/2011 | US20110171311 Stable hydrogel compositions including additives |
| 07/14/2011 | US20110171310 Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171271 Citrate-Based Dialysate Chemical Formulations |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171186 Chondrocyte therapeutic delivery system |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171138 Substantially pure deferasirox and processes for the preparation thereof |
| 07/14/2011 | DE102010004431A1 Pathogenesis of migraine, which is the causal therapy in the removal of perivascular edema of the dura-vascular of the brain using acetazolamide to treat migraine pain |
| 07/14/2011 | CA2784921A1 Salts and crystalline forms of a factor xa inhibitor |
| 07/14/2011 | CA2784904A1 Methods of synthesizing factor xa inhibitors |